Therapeutic agent

L-Glutamine

AnecdotalEvidence level
0Registered trials
1Conditions
0Study references

Evidence Summary

Evidence Level
Anecdotal
Mechanism
Not specified
Safety
Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing
See linked studies/trials for reported doses and durations; typical protocols vary widely.
Depletion documented; acute COVID RCT benefit on hospital stay. Alternative TCA substrate. 5-10g/day typical. GI tolerance variable. Supportive for gut/immune recovery; limited PASC-specific data.

Key Studies / References

  • See linked studies